Prevention and Public Health Fund (Affordable Care Act): Enhanced Surveillance for New Vaccine Preventable Disease

The Department of Health and Human Services Centers for Disease Control and Prevention operates the Prevention and Public Health Fund (Affordable Care Act): Enhanced Surveillance for New Vaccine Preventable Disease program (CFDA 93.533), which funded its most recent grant award on August 1, 2011—over 15 years ago.

This program supports a network of sites conducting surveillance and data collection on new vaccine use, the impact of new and emerging vaccines and other immunoprophylaxis, and new vaccine policies under consideration. The portfolio shows a single Cooperative Agreement award of $3.4 million obligated federal dollars, issued to support enhanced surveillance infrastructure for vaccine-preventable disease monitoring. That award (U01IP000458, completed July 31, 2017) represented the entirety of recorded program activity.

The program appears inactive by standard grant-funding measures. No grant opportunities have been posted recently, no new awards have been issued since 2011, and the source provides no indication of current solicitation activity or upcoming application deadlines. The program structure is exclusively Cooperative Agreements, but the absence of any recent funding activity makes the assistance-type mix immaterial to pursuit decisions.

Given the 15-year gap since the last award and the absence of any current or recent grant opportunities in the source material, this program does not present an active funding avenue at this time. Organizations interested in federal surveillance funding for vaccine-preventable diseases should monitor CDC announcements for potential program reactivation, but should not assume current receptivity to new applications under this Assistance Listing.